Click "+" sign to expend titles, and click a section title to read "Instruction".

(Note: Web users are allowed to review titles and instructions. To use the full functions of writing SAP in Word document and using search-engine to retrieve text from protocol or other Word documents, please contact us.)

Skip Navigation Links.
Collapse Contents of Statistical Analysis PlanContents of Statistical Analysis Plan
1. STUDY SYNOPSIS
Collapse  2. STUDY OBJECTIVES 2. STUDY OBJECTIVES
2.1 Primary Objective
2.2 Secondary Objectives
2.3 Assessment of Objectives
2.4 Change the Primary Objective During the Conduct of the Study
Collapse  3. STUDY DESIGN 3. STUDY DESIGN
3.1 General Design and Plan
3.2 Sample Size
Expand  3.3 Randomization and Blinding 3.3 Randomization and Blinding
3.4 Study Assessments
Collapse  4. STUDY POPULATIONS 4. STUDY POPULATIONS
4.1 Subject Disposition
4.2 Definition of Populations for Analysis
4.3 Efficacy Evaluable
4.4 Intent-to-treat (ITT)
4.5 Per Protocol (PP)
4.6 Safety Population
4.7 Major Protocol Deviations
4.8 Definition of Sub-Group Population in Different Analyses
Collapse  5. STATISTICAL ANALYSIS 5. STATISTICAL ANALYSIS
5.1 General
5.2 Pooling of Sites
5.3 Interim Analyses
5.4 Time-Points For Analysis
Expand  5.5 Methods for Handling Missing Data 5.5 Methods for Handling Missing Data
Expand  5.6 Statistical Analytical Issues 5.6 Statistical Analytical Issues
Collapse  6. EVALUATION OF DEMOGRAPHICS AND BASELINE CHARACTERISTICS 6. EVALUATION OF DEMOGRAPHICS AND BASELINE CHARACTERISTICS
Expand  6.1 Demographics and Baseline Characteristics 6.1 Demographics and Baseline Characteristics
Expand  6.2 Medical History and Prior Medical Therapy 6.2 Medical History and Prior Medical Therapy
Expand  6.3 Prior Therapies and Medications 6.3 Prior Therapies and Medications
Collapse  7. EVALUATION OF TREATMENT COMPLIANCE AND EXPOSURE 7. EVALUATION OF TREATMENT COMPLIANCE AND EXPOSURE
Expand  7.1 Compliance to Study Drug and Treatment 7.1 Compliance to Study Drug and Treatment
Expand  7.2 Exposure to Study Drug 7.2 Exposure to Study Drug
Collapse  8. EVALUATION OF PHARMACOKINETICS 8. EVALUATION OF PHARMACOKINETICS
8.1 Evaluation of Pharmacokinetics
8.2 Pharmacokinetic Parameters
8.3 Bioequivalent
Collapse  9. EVALUATION OF EFFICACY PARAMETERS 9. EVALUATION OF EFFICACY PARAMETERS
Expand  9.1 Analysis of Primary, Secondary, and Other Efficacy Endpoints 9.1 Analysis of Primary, Secondary, and Other Efficacy Endpoints
Expand  9.2 Method for Analysis of Efficacy Endpoints 9.2 Method for Analysis of Efficacy Endpoints
Collapse  10. EVALUATION OF SAFETY PARAMETERS 10. EVALUATION OF SAFETY PARAMETERS
Expand  10.1 Adverse Events 10.1 Adverse Events
Expand  10.2 Clinical Laboratory Evaluation 10.2 Clinical Laboratory Evaluation
Expand  10.3 Concomitant Medications 10.3 Concomitant Medications
Expand  10.4 Vital Signs and Physical Examinations 10.4 Vital Signs and Physical Examinations
Expand  10.5 Other Safety Evaluations 10.5 Other Safety Evaluations